Treatment Indications: correction of facial wrinkles and folds (nasolabial folds, marionette lines);, restoration of facial volume and contours (cheeks, cheekbones, chin, jawline, temples);, addressing age-related volume loss;, biostimulation of neocollagenesis for sustained skin rejuvenation
Release form: 2 × 1 mL pre-filled sterile syringes
Compound: 30% polycaprolactone (PCL) microspheres (25–50 μm, smooth spherical particles, non-animal origin) suspended in 70% carboxymethylcellulose (CMC) gel carrier
Concentration of GC: not applicable (PCL-based filler, not hyaluronic acid); PCL microspheres — 30%
Lidocaine: No
Indications: injection into mid-to-deep dermis or subcutaneous layer;, dual-action mechanism — immediate volumizing effect from CMC gel carrier followed by gradual stimulation of collagen type I production as PCL microspheres act as a scaffold;, CMC carrier resorbed within 2–3 months and replaced by new collagen; effect duration approximately 18 months